Importer of Controlled Substances Registration, 52136 [2019-21321]
Download as PDF
<![CDATA[
52136
Federal Register / Vol. 84, No. 190 / Tuesday, October 1, 2019 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 18, 2019, Noramco
Inc., 1550 Olympic Drive, Athens,
Georgia 30601 applied to be registered
as an importer of the following basic
classes of controlled substances:
Controlled substance
Drug
code
Schedule
approved or non-approved finished
dosage forms for commercial sale.
Phenylacetone ..................
Thebaine ...........................
Poppy Straw Concentrate
Tapentadol ........................
8501
9333
9670
9780
II
II
II
II
Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator Deputy
Assistant Administrator.
ADDRESSES:
Controlled substance
Drug
code
Schedule
Marihuana Extract ............
Marihuana .........................
Tetrahydrocannabinols .....
Nabilone ...........................
7350
7360
7370
7379
I
I
I
II
The company plans to import
phenylacetone (8501), and poppy straw
concentrate (9670) to bulk manufacture
other controlled substances for
distribution to its customers. The
company plans to import an
intermediate form of tapentadol (9780)
to bulk manufacture tapentadol (9780)
for distribution to its customers.
The company plans to import
impurities of buprenorphine that have
been determined by DEA to be captured
under drug code (9333) thebaine.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration. Placement of these
drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
Companies
jbell on DSK3GLQ082PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
18:10 Sep 30, 2019
Jkt 250001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
SUMMARY: The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
FR docket
Restek Corporation ....................................................................................
AMRI Rensselaer, Inc ................................................................................
Alcami Carolinas Corporation ....................................................................
Cambrex Charles City ................................................................................
Chattem Chemicals, Inc .............................................................................
VerDate Sep<11>2014
[FR Doc. 2019–21319 Filed 9–30–19; 8:45 am]
84
84
84
84
83
FR
FR
FR
FR
FR
35691
35692
36941
36945
39129
Published
.......................................................
.......................................................
.......................................................
.......................................................
.......................................................
granted a registration as an importer for
schedule I and II controlled substances
to the above listed companies.
Dated: September 23, 2019
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy
Assistant Administrator.
July 24, 2019.
July 24, 2019.
July 30, 2019.
July 30, 2019.
August 8, 2019.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 2, 2019.
DATES:
DEPARTMENT OF JUSTICE
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
Drug Enforcement Administration
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–21321 Filed 9–30–19; 8:45 am]
BILLING CODE 4410–09–P
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: CreaGen Inc.
ACTION:
PO 00000
Notice of application.
Frm 00077
Fmt 4703
Sfmt 4703
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 14, 2019,
CreaGen Inc., 299 Washington Street,
Unit A, Woburn, Massachusetts 01801–
2795 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Page 52136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21321]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as an importers of various basic classes of schedule I and
II controlled substances. Information on previously published notices
is listed in the table below. No comments or objections were submitted
and no requests for a hearing were submitted for these notices.
------------------------------------------------------------------------
Companies FR docket Published
------------------------------------------------------------------------
Restek Corporation........... 84 FR 35691.... July 24, 2019.
AMRI Rensselaer, Inc......... 84 FR 35692.... July 24, 2019.
Alcami Carolinas Corporation. 84 FR 36941.... July 30, 2019.
Cambrex Charles City......... 84 FR 36945.... July 30, 2019.
Chattem Chemicals, Inc....... 83 FR 39129.... August 8, 2019.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable various basic classes of schedule I and II
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each of the
company's maintenance of effective controls against diversion by
inspecting and testing each company's physical security systems,
verifying each company's compliance with state and local laws, and
reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I and II controlled substances to the above
listed companies.
Dated: September 23, 2019
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21321 Filed 9-30-19; 8:45 am]
BILLING CODE 4410-09-P
